NCT00304213
Withdrawn
Phase 4
Does Testosterone Improve Function in Hypogonadal Older Men
ConditionsHypogonadism
DrugsTestosterone
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Hypogonadism
- Sponsor
- North Florida Foundation for Research and Education
- Locations
- 1
- Primary Endpoint
- Cognitive function
- Status
- Withdrawn
- Last Updated
- 11 years ago
Overview
Brief Summary
This is a randomized controlled trial of testosterone replacement therapy in hypogonadal men age > 60 years. The goal is to assess the safety and efficacy of TRT in men age > 60 years.
Investigators
Eligibility Criteria
Inclusion Criteria
- •age 60-80 yrs serum total testosterone \< 300 ng/dL serum bioavailable testosterone \< 70 ng/dL
Exclusion Criteria
- •unable to provide informed consent history of prostate or breast cancer untreated sleep apnea
Outcomes
Primary Outcomes
Cognitive function
Physical function
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD LotionHypogonadismNCT00857168Acrux DDS Pty Ltd36
Completed
Phase 2
A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion FormulationsHypogonadismNCT00857961Eli Lilly and Company21
Withdrawn
Phase 3
Does Testosterone Therapy Improve Patient-Reported Outcomes in Age-Related Testosterone Deficient Patients Undergoing Total Hip Replacement: A Randomized-Controlled TrialArthroplasty, Replacement, HipNCT05722301American Hip Institute
Completed
Phase 2
Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal MalesHypogonadismNCT00372008Acrux DDS Pty Ltd40
Completed
Not Applicable
Evaluation of Testosterone therapy in Heart FailureIRCT2013070113828N1Islamic Azad University, Najafabad Branch50